|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antioxidant activity, ascorbic acid and total phenol of exotic fruits occurring in Brazil显示文摘 | Aparecida de Assis S Vellosa J C R Brunetti I L | 2008 | International journal of food sciences and nutrition2008，60，5： | 1 |
| 2 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | | 0，，13： | 1 |
| 3 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest 显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 4 | Phase Ⅲ trial of infusional fluorouraeil, leucovorin, oxaliplatin, and irinoteean ( FOLFOXI- RI) compared with infusional fluorouraeil, leueovorin, and irino- tecan(FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oneologieo Nord Ovest显示文摘 | Faleone A Rieci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 5 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，： | 1 |
| 6 | Nanonetworks: A New Communication Paradigm 显示文摘 | Akyildiz I F Brunetti F Bl6zquez C | 2008 | Computer Networks2008，52，12： | 1 |
| 7 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | | 0，，： | 1 |
| 8 | Transgene expression of green fluorescent protein and germ line transmission in cloned pigs derived form in vitro transfected adult fibroblasts 显示文摘 | Brunetti D Perota A Lagutina I | 2008 | Cloning Stem Cells2008，10，4： | 1 |
| 9 | Phase ill trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FO LFIRI) as first -line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest 显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 10 | Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor显示文摘 | Brunetti A Goldfine I D | 1990 | J Biol Chem1990，265，： | 1 |
| 11 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOX- IRI) compared with infusional fluorouracil, leucovorin, and iri- notecan (FOLFIRI) as first-line treatment for metastatic colorectalcancer: the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin 0ncol2007，25，13： | 1 |
| 12 | Phase III trial of infusional flu-orouracil ,leucovorin,oxaliplatin, and irinotecan ( FOLFOXIRI )compared with infusional fluorouracil, leucovorin, and irinotecan(FOLFIRI) as first - line treatment for metastatic colorectal canc-er ;The Gruppo Oncologicol Nord Ovest 显示文摘 | Falcone A Ricci S Brunetti I | 2007 | Clin Oncol2007，25，13： | 1 |
| 13 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) com- pared with infusional fluomuracil, leucovorin, and irlnotecan (FOLFIRI) as first -line treatment for metastatic colorectal cancer: the Gruppo On- cologico Nord Ovest显示文摘 | FALCONE A RICCI S BRUNETTI I | 2007 | J Cfin Oneol2007，25，13： | 1 |
| 14 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluoroucacil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 15 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 16 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan ( FOL- FOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncalogico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 17 | Phase III trial of infusional flu-orouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) com-pared with infusional fluorouracil,leucovorin,and irinotecan(FOLFI-RI)as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ove显示文摘 | Falcone A Ricci S Brunetti I | | 0，，： | 1 |
| 18 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusianal fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 19 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan(FOLFOXIRI)compared with infusional fluorouracil,leucovorin,and irinotecan(FOLFIRI)as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | FALCONE A RICCI S BRUNETTI I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 20 | Phase III trial of infusional fluorouracil,leucovorin,ox-aliplatin,and irinotecan(FOLFOXIRI)compared with infusional fluorouracil,leucovorin,and irinotecan(FOLFIRI)as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | FALCONE A RICCI S BRUNETTI I | 2007 | J Clin Oncol2007，25，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员